Sign in
4

Changes in Ownership

Petros Pharmaceuticals, Inc. Filed Acc 0001104659-23-053224

Director acquired 6,722 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silverman Joshua Director 2023-04-26 Option exercise +6,722 11,237 D
Derivatives
Silverman Joshua Director 2023-04-26 Option exercise · Restricted Stock Units −6,722 0 D
Loading xslF345X04/tm2313909-1_4seq1.xml…